Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A ReceptorsXavier Viñals, Patricia Robledo, Estefanía Moreno et al.|PLoS Biology|2015Cited by 212
Orexin–Corticotropin-Releasing Factor Receptor Heteromers in the Ventral Tegmental Area as Targets for CocaineGemma Navarro, Peter J. McCormick, César Quiroz et al.|Journal of Neuroscience|2015Cited by 74
Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal StriatumEstefanía Moreno, Manuel Guzmán, Anna Chiarlone et al.|Neuropsychopharmacology|2017Cited by 67
Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's diseaseDavid Moreno‐Delgado, Peter J. McCormick, Mar Puigdellívol et al.|eLife|2020Cited by 33
Author response: Modulation of dopamine D1 receptors via histamine H3 receptors is a novel therapeutic target for Huntington's diseaseDavid Moreno‐Delgado, Peter J. McCormick, Mar Puigdellívol et al.|Unknown|2020Cited by 1